WHY IT MATTERS: If you are currently using commercially available hemp-derived intoxicants such as delta-8 or delta-10 products, you may be consuming synthetic cannabinoids or illegal THC levels without any labeling disclosure to warn you. CLINICAL OVERVIEW: Unregulated intoxicating hemp products pose a serious public health concern because many contain delta-9 THC concentrations above the federal 0.3% legal threshold, effectively making them unregistered cannabis products sold without the consumer protections of a licensed dispensary system. More alarming is the presence of synthetic cannabinoids in a significant proportion of these products, compounds with unpredictable pharmacology, narrow safety margins, and no established therapeutic dosing data.
Indiana hemp drug ban, early voting restrictions die at deadline
WHY IT MATTERS: If you are an Indiana resident currently using hemp-derived THC products for symptom management, your access remains unchanged for now, but you should still exercise caution because these products remain largely unregulated for potency, purity, and accurate labeling. CLINICAL OVERVIEW: Indiana’s proposed ban on intoxicating hemp-derived THC products failed to advance before a legislative deadline, leaving the current market for these products intact for now. This outcome means that consumers in Indiana will continue to have access to hemp-derived THC products that exist in a regulatory gray area under the 2018 Farm Bill, though the lack of comprehensive regulation also means product safety and labeling standards remain inconsistent.